Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Cantabilin (4-methylumbelliferone)
i
Other names:
4-MU, 7-hydroxy-4-methylcoumarin
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
UAB University - Birmingham
Drug class:
Hyaluronic acid synthase inhibitor
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
HAS3 expression
Renal Cell Carcinoma
HAS3 expression
Renal Cell Carcinoma
sorafenib + 4-methylumbelliferone
Sensitive: D – Preclinical
sorafenib + 4-methylumbelliferone
Sensitive
:
D
sorafenib + 4-methylumbelliferone
Sensitive: D – Preclinical
sorafenib + 4-methylumbelliferone
Sensitive
:
D
UGT1A9 expression
Renal Cell Carcinoma
UGT1A9 expression
Renal Cell Carcinoma
sorafenib + 4-methylumbelliferone
Sensitive: D – Preclinical
sorafenib + 4-methylumbelliferone
Sensitive
:
D
sorafenib + 4-methylumbelliferone
Sensitive: D – Preclinical
sorafenib + 4-methylumbelliferone
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.